| Literature DB >> 22997192 |
Andres Morales La Madrid1, Melanie Beglin Nall, Karen Ouyang, Agata Minor, Gordana Raca, Paul Kent, Ira Miller, Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Susan L Cohn.
Abstract
Surgery alone is curative for most children with localized MYCN-non-amplified neuroblastoma. However, 10-15% will develop recurrent loco-regional disease, and very rarely, patients will relapse metastatically. Currently, it is not possible to predict which child with localized, MYCN-non-amplified neuroblastoma will develop disseminated disease. We report two children who presented with favorable biology, localized neuroblastoma and subsequently relapsed with metastatic disease after treatment with surgery. Whole-genome DNA copy number analyses performed on the diagnostic tumors identified 15 (case 1) and 8 (case 2) segmental chromosomal alterations. Further analysis of the prognostic value of whole-genome analysis in children with localized neuroblastoma is warranted.Entities:
Mesh:
Year: 2012 PMID: 22997192 DOI: 10.1002/pbc.24311
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167